About
Partner in King & Spalding's FDA and Life Sciences practice with nearly 25 years of experience advising companies on regulatory, legislative, and litigation strategies for FDA-regulated products, including drugs, devices, biologics, cosmetics, and tobacco. Previously served as a Senior Policy Advisor in the FDA Commissioner's Office and Deputy Chief of Staff to the Commissioner of Food and Drugs, providing strategic counsel on issues such as off-label marketing, digital health, opioid misuse, in vitro diagnostics, cosmetic regulation, and antimicrobial drug development.
Practice areas
FDA RegulationLife SciencesHealthcareRegulatoryLitigation
Office
Expertise
FDA RegulationLife SciencesRegulatory StrategyLitigationPolicy AdvisoryDrug DevelopmentDevice RegulationBiologicsCosmetics RegulationTobacco RegulationDigital HealthOpioid Policy